PetMedix raises USD37m in Series B round
PetMedix has completed an oversubscribed USD37 million (GBP27 million) Series B financing round that will be used to advance its innovative pipeline through clinical development. The investment brings two new investors into PetMedix: global technology company Tencent and Japanese corporation Kyoritsu Holdings alongside strong continued support from US-based investor Digitalis
